Table 2 Meta-analysis results
Study | Patient taking Els | Patient taking Tsls | OS | PFS | TTFS | DEATH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | CI 95% | Hetetrogeneity test | HR | CI 95% | Hetetrogeneity test | HR | CI 95% | Hetetrogeneity test | RR | CI 95% | Hetetrogeneity test | |||
Iacovelli et al. | 65 | 24 | 0.88 | 0.44–1.78 | Q = 3.61 p-value = 0.462 I2 = 0% | 0.92 | 0.56–1.51 | Q = 15.76 p-value = 0.003 I2 = 74.6% | 0.78 | 0.48–1.27 | Q = 10.84 p-value = 0.004 I2 = 81.6% | – | – | Q = 0.74 p-value = 0.690 I2 = 0% |
Alimohamed et al. | 115 | 130 | 0.77 | 0.52–1.15 | – | – | 0.774 | 0.52–1.153 | – | – | ||||
Wong et al. | 223 | 178 | 0.60 | 0.42–0.85 | 0.73 | 0.54–0.97 | – | – | 0.939 | 0.76–1.160 | ||||
Harrison et al. | 19 | 37 | – | – | 0.54 | 1.13–3.61 | – | – | – | – | ||||
Chen et al. | 117 | 75 | 1.03 | 0.59–1.79 | 0.48 | 0.30–0.79 | 2.05 | 1.26–3.35 | 0.716 | 0.398–1.288 | ||||
Patel et al. | 59 | 31 | 0.58 | 0.31–0.97 | 1.03 | 0.63–1.69 | – | – | 0.78 | 0.224–3.425 | ||||